Trefoil Therapeutics is a clinical-stage biotechnology company dedicated to restoring sight to individuals suffering from corneal diseases. The company is advancing two products based on its lead candidate, TTHX1114, an engineered form of Fibroblast Growth Factor (FGF1), which has the potential to be a first-in-class treatment for various corneal conditions. TTHX1114 is being developed in both intracameral injection and topical formulations to address corneal endothelial and epithelial diseases, respectively. With a strong management team boasting over 100 years of collective experience in ophthalmic drug development, Trefoil has garnered significant support through venture financing and collaborations, including a notable agreement with the NIH. The company aims to improve visual recovery rates and patient outcomes in those with limited therapeutic options.

San Diego, CA, USA

Trefoil Therapeutics

Correlation Ventures

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Correlation Ventures Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Correlation Ventures network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Correlation Ventures company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Companies you’ll love to work for